The Biotech ETF, IBB, is up more than 50% in 2013, quite a performance for a relatively well distributed ETF with no one component comprising more than 9% of the ETF’s weight. The rally in …
Continue readingGILD
Through all the ebbs and flows in 2013, the leaders have been pretty consistent. Biotechs, TSLA, NFLX, and social media stocks have been the big winners (I detailed the leaders in my Macro Wrap earlier …
Continue readingThe Nasdaq 100 index made a new multiy-year high this week, cleanly breaking above the 3,150 level on Monday. The index only traded at these levels during the go-go days of 2000: Of course, the …
Continue readingWith not much new to report on the macro front (little movement among asset classes overnight), I wanted to focus a bit more micro in the heart of earnings season. Specifically, what are this year’s …
Continue readingThe health care sector has been on fire in 2013. But within health care, biotech stocks have been absolutely blazing. The Biotech sector is a leader on the upside once again today. AMGN, BIIB, CELG, …
Continue reading